Biomarker-guided antibiotic therapy-Strengths and limitations

Cited By :1 Export Date: 19 October 2017 Correspondence Address: Nora, D.; NOVA Medical School, New University of Lisbon, Rua Francisco Ferrer, 2-1D, Portugal; email: davidjgarcianora@gmail.com Chemicals/CAS: C reactive protein, 9007-41-4; procalcitonin, 56645-65-9 References: Zilahi, G., Artigas, A...

Full description

Bibliographic Details
Main Author: Nora, D. (author)
Other Authors: Salluh, J. (author), Martin-Loeches, I. (author), Póvoa, P. (author)
Format: review
Language:eng
Published: 2017
Subjects:
Antibiotic
Biomarkers
C-reactive protein (CRP)
Infection
Procalcitonin (PCT)
biological marker
C reactive protein
procalcitonin
antibiotic therapy
clinical decision making
clinical practice
control strategy
cost effectiveness analysis
critically ill patient
data analysis
health care cost
human
intensive care unit
mortality
outcome assessment
primary medical care
randomized controlled trial (topic)
Review
treatment duration
treatment failure
SDG 3 - Good Health and Well-being
Online Access:https://doi.org/10.21037/atm.2017.04.04
Country:Portugal
Oai:oai:run.unl.pt:10362/24347

Internet

https://doi.org/10.21037/atm.2017.04.04

Similar Items